Lead Sponsor

Cardiovascular Research Center, Brazil

Collaborators

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•1. patients \>18 years of age,
•2. clinical indication for PCI with stent implantation of at least one angiographically documented coronary artery lesion,
•3. agreement to undergo all protocol clinical follow-ups. 4 - presence of at least one obstruction \>50% diameter stenosis by visual estimation in a major epicardial vessel or a major branch (≥2.50mm), with coronary anatomy suitable for percutaneous treatment with implantation of the Endeavor ZES.

•1. ST-elevation acute MI presenting for primary or rescue PCI;
•2. DES in-stent restenosis;
•3. PCI with bare metal stents \<6 months prior to index procedure;
•4. previous treatment with any DES;
•5. scheduled elective surgery within 12 months post index procedure;
•6. contra-indication, intolerance, or known hypersensibility to aspirin and/or clopidogrel;
•7. known illness with life expectancy \<36 months; and impossibility to comply with all protocol follow-ups.
•8. target lesion(s) located in saphenous vein grafts,
•9. coronary anatomy unsuitable for percutaneous treatment with implantation of the Endeavor ZES.

Related studies

NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis

NCT06779630 · Coronary Artery Disease

NCT07565805 · Coronary Artery Disease (CAD)

NCT07560436 · Heart Failure With Preserved Ejection Fraction (HFPEF), Coronary Artery Disease

NCT07324720 · Coronary Artery Disease

Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor - Optimize Trial